Literature DB >> 6420706

Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus.

A C Hayday, S D Gillies, H Saito, C Wood, K Wiman, W S Hayward, S Tonegawa.   

Abstract

A tissue-specific transcriptional enhancer element that is associated with the human immunoglobulin heavy-chain locus is defined. In a non-Hodgkin's lymphoma that contains a translocated c-myc gene this enhancer is retained on the 14q+ chromosome and occurs within sequences shown to activate previously cryptic promoters of the c-myc gene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420706     DOI: 10.1038/307334a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  80 in total

1.  Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability.

Authors:  A Hellman; A Rahat; S W Scherer; A Darvasi; L C Tsui; B Kerem
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.

Authors:  N E Wittekindt; K Hörtnagel; C Geltinger; A Polack
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

3.  Stimulation of pancreatic islet beta-cell replication by oncogenes.

Authors:  M Welsh; N Welsh; T Nilsson; P Arkhammar; R B Pepinsky; D F Steiner; P O Berggren
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity.

Authors:  T Kadesch; P Zervos; D Ruezinsky
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

5.  A 5'-truncated c-myc gene variant not associated with a risk of cancer.

Authors:  N S Pellegata; G Bergamaschi; D Amadori; A Aloia; P Ballarini; L Del Senno; L Amaducci; G N Ranzani
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

6.  The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.

Authors:  Monica Cardone; Ayten Kandilci; Cintia Carella; Jonas A Nilsson; Jennifer A Brennan; Sema Sirma; Ugur Ozbek; Kelli Boyd; John L Cleveland; Gerard C Grosveld
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 7.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

8.  Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes.

Authors:  K Nishikura; S Goldflam; G A Vuocolo
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

9.  NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.

Authors:  L Ji; M Arcinas; L M Boxer
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Translocation and rearrangement of c-myc into immunoglobulin alpha heavy chain locus in primary cells from acute lymphocytic leukemia.

Authors:  C Peschle; F Mavilio; N M Sposi; A Giampaolo; A Caré; L Bottero; M Bruno; G Mastroberardino; R Gastaldi; M G Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.